单途径和双途径灌注化疗治疗晚期肝癌及疗效比较  

作　　者：李柏[1] 冯晓灵[1] 万向荣[1] 徐卫东[1] 赵宗民[1] 张国龙[1] 

机构地区：[1]中国人民解放军九七医院,221004

出　　处：《综合临床医学》1994年第2期82-84,共3页

摘　　要：Ⅲ期原发性肝癌患者44例,行肝动脉单途径灌注化疗29例,行肝动脉、门静脉双途径灌注化疗15例.结果:两组肿瘤缓解率、AFP下降率相近,平均治后生存期无显著性差异.但双途径组治后半年以上生存率显著高于单途径组,且有两例门静脉癌栓缩小.in 44 cases of stage b prmiary hepatic caicn.oma, 29 cases were treated with cbemotherapeuuant infusion through the hep atie artery and 15 cases through both the hepatic artery and protal vein. The results showed that there were mo significant differences in tumor remission rate,the decrease rate of serum AFP levels and the average survival time between the two groups. However,the survival rate of sixmonth in double way infusion group was signiucantly higher than that in single infusion group. Moreover the tumor emboli in portal vein shrinked in 2 rases in the combined group.

关 键 词：肝肿瘤 癌 药物疗法 灌注疗法 疗效 

分 类 号：R735.705[医药卫生—肿瘤]